Kunchithapadam Swaminathan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kunchithapadam Swaminathan has a total of 157 co-authors. Here are the top co-authors by number of shared publications:
Gayathri Gopalan
Department of Biological Sciences, National University of Singapore, Singapore 117543
6 shared publications- Kuntal Pal
Department of Bio-Sciences, School of Bio Sciences and Technology (SBST), Vellore Institute of Technology, Vellore, India
4 shared publications - Chacko Jobichen
Centre for Advanced Microscopy Australian National University Canberra Australian Capital Territory Australia
3 shared publications - Dileep Vasudevan
Institute of Life Sciences
3 shared publications Sheng Luan
Department of Plant and Microbial Biology University of California Berkeley CA USA
3 shared publications- Sheng Luan
Department of Plant and Microbial Biology, University of California, Berkeley, Berkeley, USA
3 shared publications
Latest Publications
- Open Access
- 2 November 2022
- Published by Wiley in Cell Proliferation
- Vol. 56 (1)
A NR2E1‐interacting peptide of LSD1 inhibits the proliferation of brain tumour initiating cells
Objectives: Elimination of brain tumour initiating cells (BTICs) is important for the good prognosis of malignant brain tumour treatment. To develop a novel strategy targeting BTICs, we studied NR2E1(TLX) involved self‐renewal mechanism of BTICs and explored the intervention means.Materials and Methods: NR2E1 and its interacting protein‐LSD1 in BTICs were studied by gene interference combined with cell growth, tumour sphere formation, co‐immunoprecipitation and chromatin immunoprecipitation assays. NR2E1 interacting peptide of LSD1 was identified by Amide Hydrogen/Deuterium Exchange and Mass Spectrometry (HDX‐MS) and analysed by in vitro functional assays. The in vivo function of the peptide was examined with intracranial mouse model by transplanting patient‐derived BTICs.Results: We found NR2E1 recruits LSD1, a lysine demethylase, to demethylate mono‐ and di‐methylated histone 3 Lys4 (H3K4me/me2) at the Pten promoter and repress its expression, thereby promoting BTIC proliferation. Using Amide Hydrogen/Deuterium Exchange and Mass Spectrometry (HDX‐MS) method, we identified four LSD1 peptides that may interact with NR2E1. One of the peptides, LSD1‐197‐211 that locates at the LSD1 SWIRM domain, strongly inhibited BTIC proliferation by promoting Pten expression through interfering NR2E1 and LSD1 function. Furthermore, overexpression of this peptide in human BTICs can inhibit intracranial tumour formation.Conclusion: Peptide LSD1‐197‐211 can repress BTICs by interfering the synergistic function of NR2E1 and LSD1 and may be a promising lead peptide for brain tumour therapy in future.
- 2 November 2022
- Published by Wiley in Cell Proliferation
- Vol. 56 (1)
Open AccessA NR2E1‐interacting peptide of LSD1 inhibits the proliferation of brain tumour initiating cells
Objectives: Elimination of brain tumour initiating cells (BTICs) is important for the good prognosis of malignant brain tumour treatment. To develop a novel strategy targeting BTICs, we studied NR2E1(TLX) involved self‐renewal mechanism of BTICs and explored the intervention means.Materials and Methods: NR2E1 and its interacting protein‐LSD1 in BTICs were studied by gene interference combined with cell growth, tumour sphere formation, co‐immunoprecipitation and chromatin immunoprecipitation assays. NR2E1 interacting peptide of LSD1 was identified by Amide Hydrogen/Deuterium Exchange and Mass Spectrometry (HDX‐MS) and analysed by in vitro functional assays. The in vivo function of the peptide was examined with intracranial mouse model by transplanting patient‐derived BTICs.Results: We found NR2E1 recruits LSD1, a lysine demethylase, to demethylate mono‐ and di‐methylated histone 3 Lys4 (H3K4me/me2) at the Pten promoter and repress its expression, thereby promoting BTIC proliferation. Using Amide Hydrogen/Deuterium Exchange and Mass Spectrometry (HDX‐MS) method, we identified four LSD1 peptides that may interact with NR2E1. One of the peptides, LSD1‐197‐211 that locates at the LSD1 SWIRM domain, strongly inhibited BTIC proliferation by promoting Pten expression through interfering NR2E1 and LSD1 function. Furthermore, overexpression of this peptide in human BTICs can inhibit intracranial tumour formation.Conclusion: Peptide LSD1‐197‐211 can repress BTICs by interfering the synergistic function of NR2E1 and LSD1 and may be a promising lead peptide for brain tumour therapy in future.
- Open Access
- 23 October 2020
- Published by Wiley in FEBS Letters
- Vol. 595 (1) , 145-154
Structural and functional analyses of the PPIase domain ofArabidopsis thalianaCYP71 reveal its catalytic activity toward histone H3
Arabidopsis thalianaCYP71 (AtCYP71) is a chromatin‐remodeling protein that promotes shoot apical meristem (SAM) differentiation. The N terminus of AtCYP71 contains a noncanonical WD domain, and the C terminus contains an enzymatic peptidyl‐prolyl isomerase (PPIase) cyclophilin (CYP) domain. To date, there has been no characterization of CYP71, and its mode of action remains unknown. Here, we report the crystal structure of the CYP domain of AtCYP71 at 1.9 Å resolution. The structure shows key differences when compared to the canonical CYP fold of human CypA. To the best our knowledge, this is the firstA. thalianaCYP structure with a conserved active site loop. Using nuclear magnetic resonance spectroscopy, we demonstrate that the CYP domain is active toward histone H3. Our findings suggest that the PPIase activity of the CYP domain is important for the function of AtCYP71 in chromatin remodeling during organogenesis.
- 23 October 2020
- Published by Wiley in FEBS Letters
- Vol. 595 (1) , 145-154
Open AccessStructural and functional analyses of the PPIase domain ofArabidopsis thalianaCYP71 reveal its catalytic activity toward histone H3
Arabidopsis thalianaCYP71 (AtCYP71) is a chromatin‐remodeling protein that promotes shoot apical meristem (SAM) differentiation. The N terminus of AtCYP71 contains a noncanonical WD domain, and the C terminus contains an enzymatic peptidyl‐prolyl isomerase (PPIase) cyclophilin (CYP) domain. To date, there has been no characterization of CYP71, and its mode of action remains unknown. Here, we report the crystal structure of the CYP domain of AtCYP71 at 1.9 Å resolution. The structure shows key differences when compared to the canonical CYP fold of human CypA. To the best our knowledge, this is the firstA. thalianaCYP structure with a conserved active site loop. Using nuclear magnetic resonance spectroscopy, we demonstrate that the CYP domain is active toward histone H3. Our findings suggest that the PPIase activity of the CYP domain is important for the function of AtCYP71 in chromatin remodeling during organogenesis.
- 1 April 2019
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 126, 229-237
Engineering of serine protease for improved thermostability and catalytic activity using rational design
- 1 April 2019
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 126, 229-237
Engineering of serine protease for improved thermostability and catalytic activity using rational design
- Open Access
- 1 August 2018
- Published by Elsevier in Cell Reports
- Vol. 24 (8) , 1996-2004
Proteobacterial Origin of Protein Arginine Methylation and Regulation of Complex I Assembly by MidA
- 1 August 2018
- Published by Elsevier in Cell Reports
- Vol. 24 (8) , 1996-2004
Open AccessProteobacterial Origin of Protein Arginine Methylation and Regulation of Complex I Assembly by MidA
- 1 January 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 495 (2) , 1752-1757
Tilapia and human CLIC2 structures are highly conserved
- 1 January 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 495 (2) , 1752-1757
Tilapia and human CLIC2 structures are highly conserved
- Open Access
- 1 May 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (19) , 8092-8100
Yersinia effector protein (YopO)-mediated phosphorylation of host gelsolin causes calcium-independent activation leading to disruption of actin dynamics
- 1 May 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (19) , 8092-8100
Open AccessYersinia effector protein (YopO)-mediated phosphorylation of host gelsolin causes calcium-independent activation leading to disruption of actin dynamics
- Open Access
- 4 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 39998
Mechanisms of Yersinia YopO kinase substrate specificity
Yersiniabacteria cause a range of human diseases, including yersiniosis, Far East scarlet-like fever and the plague.Yersiniaemodulate and evade host immune defences through injection ofYersiniaouter proteins (Yops) into phagocytic cells. One of the Yops, YopO (also known as YpkA) obstructs phagocytosis through disrupting actin filament regulation processes - inhibiting polymerization-promoting signaling through sequestration of Rac/Rho family GTPases and by using monomeric actin as bait to recruit and phosphorylate host actin-regulating proteins. Here we set out to identify mechanisms of specificity in protein phosphorylation by YopO that would clarify its effects on cytoskeleton disruption. We report the MgADP structure ofYersinia enterocoliticaYopO in complex with actin, which reveals its active site architecture. Using a proteome-wide kinase-interacting substrate screening (KISS) method, we identified that YopO phosphorylates a wide range of actin-modulating proteins and located their phosphorylation sites by mass spectrometry. Using artificial substrates we clarified YopO’s substrate length requirements and its phosphorylation consensus sequence. These findings provide fresh insight into the mechanism of the YopO kinase and demonstrate that YopO executes a specific strategy targeting actin-modulating proteins, across multiple functionalities, to compete for control of their native phospho-signaling, thus hampering the cytoskeletal processes required for macrophage phagocytosis.
- 4 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 39998
Open AccessMechanisms of Yersinia YopO kinase substrate specificity
Yersiniabacteria cause a range of human diseases, including yersiniosis, Far East scarlet-like fever and the plague.Yersiniaemodulate and evade host immune defences through injection ofYersiniaouter proteins (Yops) into phagocytic cells. One of the Yops, YopO (also known as YpkA) obstructs phagocytosis through disrupting actin filament regulation processes - inhibiting polymerization-promoting signaling through sequestration of Rac/Rho family GTPases and by using monomeric actin as bait to recruit and phosphorylate host actin-regulating proteins. Here we set out to identify mechanisms of specificity in protein phosphorylation by YopO that would clarify its effects on cytoskeleton disruption. We report the MgADP structure ofYersinia enterocoliticaYopO in complex with actin, which reveals its active site architecture. Using a proteome-wide kinase-interacting substrate screening (KISS) method, we identified that YopO phosphorylates a wide range of actin-modulating proteins and located their phosphorylation sites by mass spectrometry. Using artificial substrates we clarified YopO’s substrate length requirements and its phosphorylation consensus sequence. These findings provide fresh insight into the mechanism of the YopO kinase and demonstrate that YopO executes a specific strategy targeting actin-modulating proteins, across multiple functionalities, to compete for control of their native phospho-signaling, thus hampering the cytoskeletal processes required for macrophage phagocytosis.
- Open Access
- 2 September 2016
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 2 (9) , e1601167-1601167
A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy
The intronic GGGGCC hexanucleotide repeat expansion in chromosome 9 open reading frame 72 (C9ORF72) is a prevalent genetic abnormality identified in both frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Smith-Magenis syndrome chromosomal region candidate gene 8 (SMCR8) is a protein with unclear functions. We report that C9ORF72 is a component of a multiprotein complex containing SMCR8, WDR41, and ATG101 (an important regulator of autophagy). The C9ORF72 complex displays guanosine triphosphatase (GTPase) activity and acts as a guanosine diphosphate–guanosine 5′-triphosphate (GDP-GTP) exchange factor (GEF) for RAB39B. We created Smcr8 knockout mice and found that Smcr8 mutant cells exhibit impaired autophagy induction, which is similarly observed in C9orf72 knockdown cells. Mechanistically, SMCR8/C9ORF72 interacts with the key autophagy initiation ULK1 complex and regulates expression and activity of ULK1. The complex has an additional role in regulating later stages of autophagy. Whereas autophagic flux is enhanced in C9orf72 knockdown cells, depletion of Smcr8 results in a reduced flux with an abnormal expression of lysosomal enzymes. Thus, C9ORF72 and SMCR8 have similar functions in modulating autophagy induction by regulating ULK1 and play distinct roles in regulating autophagic flux.
- 2 September 2016
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 2 (9) , e1601167-1601167
Open AccessA C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy
The intronic GGGGCC hexanucleotide repeat expansion in chromosome 9 open reading frame 72 (C9ORF72) is a prevalent genetic abnormality identified in both frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Smith-Magenis syndrome chromosomal region candidate gene 8 (SMCR8) is a protein with unclear functions. We report that C9ORF72 is a component of a multiprotein complex containing SMCR8, WDR41, and ATG101 (an important regulator of autophagy). The C9ORF72 complex displays guanosine triphosphatase (GTPase) activity and acts as a guanosine diphosphate–guanosine 5′-triphosphate (GDP-GTP) exchange factor (GEF) for RAB39B. We created Smcr8 knockout mice and found that Smcr8 mutant cells exhibit impaired autophagy induction, which is similarly observed in C9orf72 knockdown cells. Mechanistically, SMCR8/C9ORF72 interacts with the key autophagy initiation ULK1 complex and regulates expression and activity of ULK1. The complex has an additional role in regulating later stages of autophagy. Whereas autophagic flux is enhanced in C9orf72 knockdown cells, depletion of Smcr8 results in a reduced flux with an abnormal expression of lysosomal enzymes. Thus, C9ORF72 and SMCR8 have similar functions in modulating autophagy induction by regulating ULK1 and play distinct roles in regulating autophagic flux.
- 1 October 2015
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1850 (10) , 2145-2158
Plant immunophilins: a review of their structure-function relationship
- 1 October 2015
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1850 (10) , 2145-2158
Plant immunophilins: a review of their structure-function relationship